OUR EXPERTISE

At CMAX, our expert team works cohesively to support our national and international clients accelerate product development in Phase I-II studies and later-phase studies, delivering exceptional service. Our experienced team welcomes the challenges of modern, complex clinical trial protocols.

cmax-clinical-research-staff-2

Studies We Have Conducted Include:

  • Complex adaptive first-in-human (FTIH) protocols, including single-ascending dose and multiple-ascending dose (SAD/MAD) studies
  • Food-effect studies
  • Bioequivalence and bioavailability studies
  • Pharmacokinetic / pharmacodynamics (PK/PD) studies
  • Vaccine studies
  • Biosimilars
  • Gene therapy and GMO
  • Safety and tolerability - skin irritation/sensitisation protocols
  • Devices studies
  • Inhalation and nebulised drug administration studies
  • Ethnopharmacology studies
  • Microdosing
  • Proof-of-concept studies in patients
cmax-building-south-australia-1

OUR FACILITIES

Our purpose-built clinical trial unit is a fully-secure, self-contained facility which is operational 24 hours / 7 days per week.

The unit is equipped with the full range of facilities and equipment expected of leading early-phase clinical trial centres, including ambulatory cardiac telemetry monitoring, on-site processing laboratories, secure pharmacy rooms, and emergency call bells and procedures.

CMAX is able to draw on a range of expertise within the Adelaide Bio-Med City - which includes Adelaide’s flagship public hospital, universities, research institutes and imaging providers - to make even the most complex protocol feasible. Our partnerships provide access to a comprehensive range of diagnostic laboratory and biomarker testing services.

icon-bed

78-Bed Inpatient Clinic, 14-Bed Screening and Outpatient Clinic

icon-facility

3 PC2 Certified Processing Laboratories

icon-lungs

Inpatient Clinic Includes 4 Negative Pressure Rooms and 8-Bed Low Acoustic Suite

icon-lab

On-site PBMC Isolations in Collaboration with Partner Laboratory

THERAPEUTIC AREAS

We operate across a wide range of therapeutic areas and have experience with most routes of study drug administration, working with a variety of investigational products including new chemical entities (NCEs), small molecules, monoclonal antibodies, vaccines, gene therapies and biosimilars.

We have conducted studies across the following therapeutic areas:

  • Gastrointestinal
  • Immunology/anti-inflammatory
  • Allergy/respiratory
  • Dermatology
  • Pain/anaesthesia
  • Haematology
  • CNS/neurology
  • Endocrinology/metabolism
  • Cardiology
  • Infectious diseases
  • Ophthalmology
  • Rheumatology

RECRUITMENT & QUALITY

The CMAX recruitment department, comprised of a dedicated in-house marketing team and participant engagement team, enrol healthy volunteer and patient populations through a combination of digital and traditional advertising, established recruitment networks and direct communication with an active volunteer database.

The majority of participants are recruited from Adelaide and across South Australia - a region with a stable yet diverse population. CMAX’s central Adelaide CBD location ensures easy access for volunteers, helping reduce barriers to participation.

CMAX’s Quality Management System is overseen by our Quality Assurance (QA) department and ensures our studies meet global regulatory standards, irrespective of complexity.

71,000+

Healthy Volunteer Database

1.4 Million

Population In Adelaide, SA

In-House

Marketing Team & Call Centre

If you are working on a project that would benefit from CMAX's networked experience and expertise, we would love to hear from you.

DISCOVER OUR ADVANTAGE
CONTACT US TODAY!